As of Dec. 5, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Replimune Group Inc (NASDAQ: REPL) announced results from the primary analysis of the CERPASS trial evaluating RP1 in combination with cemiplimab for locally advanced or metastatic cutaneous
Deluxe Corporation (NYSE: DLX) reaffirmed its 2023 outlook, issued 2024 guidance, and detailed the North Star initiative to drive incremental $100 million of
On Monday, December 4th, the U.S. stock markets concluded in the negative territory, as investors maintained a cautious stance in anticipation of upcoming employment data.
In economic data, October witnessed a 3.6% month-over-month decline in U.S. factory orders, a stark contrast to the revised 2.3% increase in September and diverging from market forecasts of a 2.8% fall.
Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) is projected to release financial results for its third quarter ended Oct. 29, 2023, after the closing bell on Dec. 5, 2023.
The CNN Money Fear and Greed index showed further improvement in overall market sentiment, but the index remained in the "Greed" zone on Monday.
U.S. stocks closed lower on Monday after the S&P 500 index notched its strongest close since March 2022 on Friday.
New Head Of National Hispanic Cannabis Council
Last month, the National Hispanic Cannabis Council voted to appoint Aaron Lopez, who has been serving as its interim executive director, to lead the organization. He replaces Antonio Valdez.